Literature DB >> 2455566

Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.

A M Dvorak1, L Letourneau, G R Login, P F Weller, S J Ackerman.   

Abstract

The Charcot-Leyden crystal (CLC) protein is a unique constituent of eosinophils and basophils. This protein forms the hexagonal bipyramidal crystals observed in tissues at sites of eosinophil accumulations, possesses lysophospholipase activity (lysolecithin acylhydrolase E.C.3.1.1.5), and comprises an estimated 7% to 10% of total eosinophil protein. The ultrastructural localization of CLC protein was studied in mature peripheral blood eosinophils from normal donors and from patients with the idiopathic hypereosinophilic syndrome. Subcellular localization was evaluated by immunoelectron microscopy using eosinophils, both from buffy coat and purified cell suspensions, that were fixed by a variety of methods. Immunochemical detection of CLC protein employed rabbit antiserum to eosinophil CLC protein, affinity chromatography-purified monospecific IgG antibodies, and postembedding immunogold techniques. Controls for specificity included (1) omission of the primary antibody to CLC protein and (2) substitution of primary antibody with a nonimmune preimmunization serum, a protein A-purified nonimmune IgG, or a protein A-purified nonreactive IgG prepared from solid-phase CLC protein-Sepharose-absorbed anti-CLC antiserum. CLC protein was localized to a minor (approximately 5%) subpopulation of eosinophil granules. These membrane-bound cytoplasmic granules were large (greater than 0.5 mu), were devoid of crystalloid inclusions, and were morphologically compatible with persisting eosinophil primary granules. The crystalloid-containing, large, specific granules did not stain for CLC protein. Insufficient numbers of small dense granules, lipid bodies, and vesiculotubular structures were present to adequately evaluate their potential as additional sites for the subcellular localization of CLC protein. The cellular specificity of the immunogold localization of CLC protein in the eosinophil was affirmed by the absence of staining in neutrophils and lymphocytes present in the same sections. The ultrastructural immunogold localization of CLC protein (lysophospholipase) to a large, crystalloid-free granule in mature circulating eosinophils supports the persistence of a distinct "primary" granule population that serves as a major intracytoplasmic repository for this enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455566

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation.

Authors:  Shigeharu Ueki; Yui Miyabe; Yohei Yamamoto; Mineyo Fukuchi; Makoto Hirokawa; Lisa A Spencer; Peter F Weller
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-15       Impact factor: 4.806

Review 2.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

3.  RNA Seq profiling reveals a novel expression pattern of TGF-β target genes in human blood eosinophils.

Authors:  Zhong-Jian Shen; Jie Hu; Stephane Esnault; Igor Dozmorov; James S Malter
Journal:  Immunol Lett       Date:  2015-06-22       Impact factor: 3.685

Review 4.  Regulation of wound healing and fibrosis by galectins.

Authors:  Dong Yu; Ming Bu; Ping Yu; Yaping Li; Yang Chong
Journal:  J Mol Med (Berl)       Date:  2022-05-19       Impact factor: 4.599

5.  Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.

Authors:  A M Dvorak; T Furitsu; L Letourneau; T Ishizaka; S J Ackerman
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 6.  Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors:  Paneez Khoury; Peter C Grayson; Amy D Klion
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 7.  Contemporary understanding of the secretory granules in human eosinophils.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  J Leukoc Biol       Date:  2018-05-11       Impact factor: 4.962

8.  Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.

Authors:  Milica M Grozdanovic; Christine B Doyle; Li Liu; Brian T Maybruck; Mark A Kwatia; Nethaji Thiyagarajan; K Ravi Acharya; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2020-01-23       Impact factor: 10.793

9.  Galectin-10, the protein that forms Charcot-Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils.

Authors:  Rossana C N Melo; Haibin Wang; Thiago P Silva; Yoshimasa Imoto; Shigeharu Fujieda; Mineyo Fukuchi; Yui Miyabe; Makoto Hirokawa; Shigeharu Ueki; Peter F Weller
Journal:  J Leukoc Biol       Date:  2020-02-28       Impact factor: 6.011

10.  Kinetic studies of galectin-10 release from eosinophils exposed to proliferating T cells.

Authors:  C Lingblom; K Andersson; C Wennerås
Journal:  Clin Exp Immunol       Date:  2020-11-17       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.